AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-MEDICAL LABORATORIES
Burning Rock Biotech Limited American Depositary Shares
XNAS · usd
SIC 8071 · SERVICES-MEDICAL LABORATORIES
FIGI BBG00V1JWFQ1
11.82▼ 1.43 (-10.79%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
13.25
Day's Range
11.60 – 13.51
52-Week Range
6.79 – 41.98
Volume
51.5K
Avg Volume
38.9K
Share Statistics
Shares Outstanding
Employees
674
Exchange
XNAS
Listed
2020-06-12
Share count as of December 31, 2025

Burning Rock Biotech Limited American Depositary Shares (BNR) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Burning Rock Biotech Limited American Depositary Shares (BNR)
What is Burning Rock Biotech Limited American Depositary Shares's Market Cap?
Burning Rock Biotech Limited American Depositary Shares's Market Cap is $1.3B, based on as-reported figures from SEC (XBRL) filings.
What is Burning Rock Biotech Limited American Depositary Shares's Enterprise Value?
Burning Rock Biotech Limited American Depositary Shares's Enterprise Value is $1.2B, based on as-reported figures from SEC (XBRL) filings.
What is Burning Rock Biotech Limited American Depositary Shares's Price / Sales?
Burning Rock Biotech Limited American Depositary Shares's Price / Sales is 16.7×, based on as-reported figures from SEC (XBRL) filings.
What is Burning Rock Biotech Limited American Depositary Shares's EV / Revenue?
Burning Rock Biotech Limited American Depositary Shares's EV / Revenue is 15.8×, based on as-reported figures from SEC (XBRL) filings.
What is Burning Rock Biotech Limited American Depositary Shares's EV / EBITDA?
Burning Rock Biotech Limited American Depositary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Burning Rock Biotech Limited American Depositary Shares's Revenue (TTM)?
Burning Rock Biotech Limited American Depositary Shares's Revenue (TTM) is $77.2M, based on as-reported figures from SEC (XBRL) filings.
What is Burning Rock Biotech Limited American Depositary Shares's Net Income (TTM)?
Burning Rock Biotech Limited American Depositary Shares's Net Income (TTM) is -$7.9M, based on as-reported figures from SEC (XBRL) filings.
What is Burning Rock Biotech Limited American Depositary Shares's EBITDA?
Burning Rock Biotech Limited American Depositary Shares's EBITDA is -$4.7M, based on as-reported figures from SEC (XBRL) filings.
What is Burning Rock Biotech Limited American Depositary Shares's Diluted EPS (TTM)?
Burning Rock Biotech Limited American Depositary Shares's Diluted EPS (TTM) is -0.07, based on as-reported figures from SEC (XBRL) filings.
What is Burning Rock Biotech Limited American Depositary Shares's EBITDA Margin?
Burning Rock Biotech Limited American Depositary Shares's EBITDA Margin is -6.1%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · BNRAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of CNY, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Revenues:
Revenues
YoY growth+4.6%
Cost of revenues:
Cost of revenues:
Gross Profit
% of revenue74.7%
Operating expenses:
Research and development expenses
Selling and marketing expenses
General and administrative expenses
Impairment loss on long-lived assets
Total operating expenses
Loss from operations
% of revenue-10.2%
Interest income
Interest expenses
Other income (loss), net
Foreign exchange loss, net
Loss before income tax
Income tax expenses
Net loss
% of revenue-10.3%
Net loss attributable to Burning Rock Biotech Limited
% of revenue-10.3%
Total comprehensive loss attributable to Burning Rock Biotech Limited